The relevance of P2Y12 receptor inhibitors like clopidogrel or prasugrel in MS patients has not yet been analyzed, but platelets can bind to CNS-specific lipid rafts through CD62P [31] and CD40L triggers endothelial activation [45], meaning both mediators fire neuroinflammatory processes. Here, SELP is linked to myeloid sarcoma.